Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
380 CHF | 0.00% | 0.00% | +25.41% |
Apr. 16 | Ypsomed Partners with ten23 health for Wearable Injector Product Commercialization | MT |
Apr. 12 | Dental Equipment Company Straumann Names New Chair | MT |
Evolution of the average Target Price on Ypsomed Holding AG
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Ypsomed Holding AG
Octagon Capital | |
Credit Suisse | |
Banco Santander | |
Research Capital | |
Bank of America Securities/Merrill Lynch |
EPS Revisions
- Stock Market
- Equities
- YPSN Stock
- Consensus Ypsomed Holding AG